Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 3Pain 3Breast Neoplasms 3Neurotoxicity Syndromes 2Colorectal Neoplasms 2Urinary Incontinence 1Prostatic Neoplasms 1Neoplasms 1Hematologic Neoplasms 1Emergence Delirium 1Cancer Pain 1CIPN 1Acute Pain 1

Interventions

Ketamine 3Surveys and Questionnaires 2Oxycodone 2Gabapentin 2Anesthesia, General 2Acetaminophen 2Transcutaneous Electric Nerve Stimulation 1Tea 1Ropivacaine 1Quality of Life 1Psychotherapy 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Minocycline 1Meloxicam 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1Ibuprofen 1Hydromorphone 1Fentanyl 1Ethyl Chloride 1Epinephrine 1Duloxetine Hydrochloride 1Diathermy 1Dexmedetomidine 1Cryotherapy 1Control Groups 1Circumcision, Male 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Acute Pain × Duloxetine Hydrochloride × Clear all
NCT03560427 2020-03-18

Duloxetine Potentiates the Analgesic Efficacy of Intrathecal Morphine

Assiut University

Phase NA Completed
60 enrolled

Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡